Sex differences in imaging and clinical characteristics of patients from the WAKE-UP trial.
MRI
ischemic stroke
sex
wake-up
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
03
11
2022
received:
08
09
2022
accepted:
04
11
2022
pubmed:
10
11
2022
medline:
11
2
2023
entrez:
9
11
2022
Statut:
ppublish
Résumé
Sex-based differences in acute ischemic stroke are a well-known phenomenon. We aimed to explore these differences between women and men in the Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke (WAKE-UP) trial. We compared baseline demographic and imaging characteristics (visual fluid-attenuated inversion recovery [FLAIR] positivity, relative FLAIR signal intensity, collateral status) between women and men in all screened patients. In randomized patients (i.e., those with diffusion-weighted imaging (DWI)-FLAIR mismatch), we evaluated a modifying role of sex on the treatment effect of alteplase in multivariable logistic regression, with treatment adjusted for National Institute of Health Stroke Scale (NIHSS) score and age. Dependent variables were modified Rankin Scale (mRS) score of 0-1 at 90 days and distribution of mRS scores at 90 days. Of 1362 screened patients, 529 (38.8%) were women. Women were older than men, had higher baseline NIHSS scores and smoked less frequently. FLAIR positivity of the DWI lesion was equally present in women (174/529, 33.1%) and men (273/833, 33.3%; p = 1.00) and other imaging variables also did not differ between the sexes. In a total of 503 randomized patients, of whom 178 were women (35.4%), sex did not modify the treatment effect of alteplase on mRS score 0-1 or on the total distribution of mRS scores. As in many other stroke trials, more men than women were included in the WAKE-UP trial, but the presence of a visual DWI-FLAIR mismatch and the relative FLAIR signal intensity did not differ between the sexes. The treatment effect of alteplase was not modified by sex.
Sections du résumé
BACKGROUND AND PURPOSE
Sex-based differences in acute ischemic stroke are a well-known phenomenon. We aimed to explore these differences between women and men in the Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke (WAKE-UP) trial.
METHODS
We compared baseline demographic and imaging characteristics (visual fluid-attenuated inversion recovery [FLAIR] positivity, relative FLAIR signal intensity, collateral status) between women and men in all screened patients. In randomized patients (i.e., those with diffusion-weighted imaging (DWI)-FLAIR mismatch), we evaluated a modifying role of sex on the treatment effect of alteplase in multivariable logistic regression, with treatment adjusted for National Institute of Health Stroke Scale (NIHSS) score and age. Dependent variables were modified Rankin Scale (mRS) score of 0-1 at 90 days and distribution of mRS scores at 90 days.
RESULTS
Of 1362 screened patients, 529 (38.8%) were women. Women were older than men, had higher baseline NIHSS scores and smoked less frequently. FLAIR positivity of the DWI lesion was equally present in women (174/529, 33.1%) and men (273/833, 33.3%; p = 1.00) and other imaging variables also did not differ between the sexes. In a total of 503 randomized patients, of whom 178 were women (35.4%), sex did not modify the treatment effect of alteplase on mRS score 0-1 or on the total distribution of mRS scores.
CONCLUSION
As in many other stroke trials, more men than women were included in the WAKE-UP trial, but the presence of a visual DWI-FLAIR mismatch and the relative FLAIR signal intensity did not differ between the sexes. The treatment effect of alteplase was not modified by sex.
Identifiants
pubmed: 36349887
doi: 10.1111/ene.15629
pmc: PMC10099623
doi:
Substances chimiques
Tissue Plasminogen Activator
EC 3.4.21.68
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
641-647Informations de copyright
© 2022 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Stroke. 2021 Jan;52(2):406-415
pubmed: 33493053
Stroke. 2020 Aug;51(8):2332-2338
pubmed: 32640943
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):104954
pubmed: 32807414
Eur J Neurol. 2023 Mar;30(3):641-647
pubmed: 36349887
Stroke. 2016 Oct;47(10):2618-26
pubmed: 27553032
Am J Emerg Med. 2013 Jan;31(1):178-84
pubmed: 23000320
Stroke. 2021 Jul;52(7):2338-2346
pubmed: 33980046
Neurology. 2010 Mar 2;74(9):767-71
pubmed: 20194917
Stroke. 2003 May;34(5):1114-9
pubmed: 12690218
Stroke. 2009 May;40(5):1743-9
pubmed: 19228855
J Cereb Blood Flow Metab. 2013 Jan;33(1):76-84
pubmed: 23047272
Cerebrovasc Dis. 2019;47(3-4):196-204
pubmed: 31121582
Nat Commun. 2021 Jun 2;12(1):3289
pubmed: 34078897
Neurology. 2020 Jul 7;95(1):e11-e22
pubmed: 32522796
Front Neuroendocrinol. 2020 Oct;59:100870
pubmed: 32882229
Med Care. 2006 Jan;44(1):70-80
pubmed: 16365615
Lancet Neurol. 2011 Nov;10(11):978-86
pubmed: 21978972
J Clin Neurosci. 2009 Apr;16(4):501-4
pubmed: 19201193
Maturitas. 2017 May;99:47-50
pubmed: 28364868
N Engl J Med. 2018 Aug 16;379(7):611-622
pubmed: 29766770
Ther Adv Neurol Disord. 2017 May;10(5):241-244
pubmed: 28529545
Brain Lang. 1994 Jul;47(1):155-67
pubmed: 7922475
Stroke. 2015 Mar;46(3):746-56
pubmed: 25613308
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105468
pubmed: 33227604
Neurology. 2010 Mar 23;74(12):975-81
pubmed: 20181922
Stroke. 2019 Sep;50(9):2285-2287
pubmed: 31412759
Lancet Neurol. 2008 Oct;7(10):915-26
pubmed: 18722812
Neurology. 2020 Mar 24;94(12):e1241-e1248
pubmed: 31892636
CMAJ Open. 2016 Jun 20;4(2):E331-7
pubmed: 27398382
Stroke. 2014 Apr;45(4):1018-23
pubmed: 24595591
J Stroke Cerebrovasc Dis. 2016 Nov;25(11):2569-2574
pubmed: 27618196
Stroke. 2005 Jan;36(1):62-5
pubmed: 15569865
Ann Emerg Med. 2012 Jan;59(1):27-32
pubmed: 22000770
Ann Neurol. 2018 Oct;84(4):616-620
pubmed: 30168180
Stroke. 2020 Feb;51(2):481-488
pubmed: 31826731
Stroke. 2009 Apr;40(4):1121-6
pubmed: 19211480
Stroke. 2017 Feb;48(2):367-374
pubmed: 28028149